For limb-girdle muscular dystrophy type 2A (LGMD2A), a progressive muscle disease caused by genetic defects in the CAPN3 gene, several potential therapies have been developed. Here, CAPN3 is linked to autosomal recessive limb-girdle muscular dystrophy type 2A.